Drug
Hbm7020
Hbm7020: highest development phase Phase 1, developed by Otsuka. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Otsuka
Trials
| Drug | Phase | Indication |
|---|---|---|
| HBM7020 NCT07649265 | Phase 1 | Rheumatoid Arthritis |
Latest
No recent events.
Follow Hbm7020 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.